Shorted

Microba Life Sciences (MAP) News

Latest articles and price-sensitive announcements with AI sentiment classification.

Kalkine
Positive
just now

Microba Life Sciences Gains Strong Shareholder Approval for Capital Raising and Related Party Transactions

Microba Life Sciences Limited (ASX: MAP) confirmed that all resolutions presented at its General Meeting on 24 July 2026 were successfully passed by poll, reflecting robust shareholder endorsement. This approval authorizes the microbiome diagnostics firm to advance its capital raising efforts, including issuing placement shares and options to institutional investors, related parties, and shareholders. The voting outcomes highlight significant investor confidence in the company’s strategic fina...

Continue reading
Kalkine
Neutral
just now

Microba Life Sciences Announces Q4 FY26 Report Release and Investor Webinar on 16 July 2026

Microba Life Sciences Limited (ASX: MAP), a Brisbane-based leader in microbiome health, has announced it will publish its Q4 FY26 Quarterly Activities Report, Appendix 4C, and Quarterly Investor Presentation on Thursday, 16 July 2026. Concurrently, the company will host a live Quarterly Investor Webinar at 12:00pm AEST on the same day, led by Chief Executive Officer Dr Luke Reid. This webinar offers investors a direct opportunity to engage with management and submit questions ahead of the event....

Continue reading
Kalkine
Positive
just now

Microba Life Sciences Surge Leaves Insider Moves in Focus

Highlights Share price rebound draws attention to insider activity Earlier disposals now stand out after recent momentum Ownership structure continues to reflect insider alignment Recent price movement in Microba Life Sciences has renewed interest in insider transactions, highlighting timing differences between market momentum and earlier stock disposals. Microba Life Sciences Rally Sparks Fresh Look at Insider Activity The recent upward movement in Microba Life Sciences Limited (ASX:MA...

Continue reading